Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Gross Profit (2016 - 2025)

Historic Gross Profit for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $45.3 million.

  • Orthopediatrics' Gross Profit rose 1301.55% to $45.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.1 million, marking a year-over-year increase of 1672.52%. This contributed to the annual value of $148.6 million for FY2024, which is 3356.76% up from last year.
  • Per Orthopediatrics' latest filing, its Gross Profit stood at $45.3 million for Q3 2025, which was up 1301.55% from $44.0 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Gross Profit registered a high of $45.3 million during Q3 2025, and its lowest value of $16.3 million during Q1 2021.
  • In the last 5 years, Orthopediatrics' Gross Profit had a median value of $26.7 million in 2023 and averaged $29.0 million.
  • Within the past 5 years, the most significant YoY rise in Orthopediatrics' Gross Profit was 10319.05% (2021), while the steepest drop was 518.74% (2021).
  • Over the past 5 years, Orthopediatrics' Gross Profit (Quarter) stood at $18.1 million in 2021, then increased by 17.38% to $21.2 million in 2022, then increased by 25.87% to $26.7 million in 2023, then soared by 33.13% to $35.6 million in 2024, then rose by 27.3% to $45.3 million in 2025.
  • Its Gross Profit stands at $45.3 million for Q3 2025, versus $44.0 million for Q2 2025 and $38.3 million for Q1 2025.